MedTrace Logo

Extended vs. Intermittent Beta-Lactam Infusion in ICU Sepsis

NCT07398703 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-02-10

No results posted yet for this study

Summary

This observational study compares extended versus intermittent beta-lactam infusion in sepsis patients, assessing survival, clinical cure rates, and practical ICU challenges. The findings will guide optimal antibiotic protocols, potentially improving sepsis outcomes through precision dosing strategies.

Conditions

Interventions

DRUG

Extended beta-lactam antibiotics

Group A will be receiving extended infusion of beta-lactam antibiotic over 4 hours.

DRUG

Intermittent Beta-lactam antibiotics

Group B will be receiving intermittent infusion of beta-lactam antibiotic over 30 minutes.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2027-05-31
Completion
2027-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07398703 on ClinicalTrials.gov